LINC01255

Across TCGA pan-cancer cohorts, LINC01255 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01255 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC01255 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01255 expression acts as an unfavorable survival marker, although some lineages such as BLCA and ESCA show a favorable association.

THCA, KIRP, and DLBC are the cancer types where LINC01255 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	III,IV	0.120	0.707	<.001	60	view →
KIRP	OS	Tertile	All	0.868	0.956	.005	51	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	40	view →
UVM	OS	Tertile	All	0.248	0.769	.007	36	view →
BLCA	OS	Tertile	II,III,IV	0.951	0.414	.005	27	view →
LIHC	OS	Tertile	II,III,IV	0.220	0.649	<.001	24	view →
SKCM	OS	Tertile	IV	0.247	0.752	.004	18	view →
ESCA	DFS	Tertile	II,III,IV	0.506	0.265	.027	15	view →
HNSC	OS	Tertile	All	0.612	0.759	.019	12	view →
LGG	DFS	Tertile	All	0.657	0.829	.023	9	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	9	view →
STAD	DFS	Tertile	All	0.562	0.677	.030	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01255–THCA (DFS)

Open the THCA breakdown →